Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 1, 1996, Pages 128-136

  Ma, Xin Liang ^a,c   Yue, Tian Li ^b   Lopez, Bernard L ^a   Barone, Frank C ^b   Christopher, Theodore A ^a   Ruffolo Jr , Robert R ^b   Feuerstein, Giora Z ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CHOLESTEROL; PROPRANOLOL; SCAVENGER;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CARBAZOLES; ENDOTHELIUM, VASCULAR; FREE RADICAL SCAVENGERS; HEART RATE; HYPERCHOLESTEROLEMIA; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NEUTROPHILS; PROPANOLAMINES; RABBITS;

EID: 0030430050     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. BEGOGNI, P.: Carvedilol: A new logic for the treatment of hypertension. Monde. Med. 28: 91-92, 1991.
2. BRADLEY, P. P., PRIEBET, D. S., CHRISTENSEN, R D. AND ROTHSTEIN, G. D.: Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J. Clin Invest. 76: 1713-1719, 1982.
3. BURRIS, J. F.: β-blockers, dyslipidemia, and coronary artery disease. Arch. Intern. Med. 153: 2085-2092, 1993.
4. CARLSON, L. A., BOTTIGER, L. E. AND AHFELDT, P. E.: Risk factors for myocardial infarction in the Stockholm prospective study: A 14-year follow-up focusing on the role of plasma triglycerides and cholesterol. Acta Med. Scand. 206: 351-360, 1979.
5. FLAVAHAN, N. A.: Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 85: 1927-1938, 1992.
6. FLITTER, W. D.: Free radicals and myocardial reperfusion injury. Br. Med. Bull. 49: 545-555, 1993.
7. GARG, U C AND HASSID, A.: Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin. Invest. 83: 1774-1777, 1989.
8. GRAAF, J. C. DE, BANGA, J. D., MONCADA, S., PALMER, R. M. J., DE GROOT, P. G. AND SIXMA, J. J.: Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 85: 2284-2290, 1992.
9. KITA, T., NAGANO, Y , YOKODE, M., ISHII, K., KUME, N., OOSHIMA, A., YOSHIDA, H. AND KAWAI, C.: Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. U.S.A. 84: 5928-5931, 1987.
10. KUBES, P. AND GRANGER, D. N.: Nitric oxide modulates microvascular permeability. Am. J Physiol. 262: H611-H615, 1992.
11. LARDINOIS, C. K. AND NEUMAN, S. L.: The effects of antihypertensive agents on serum lipid and lipoproteins. Arch. Intern. Med. 148: 1280-1288, 1988.
12. LEFER, A. M.: Induction of tissue injury and altered cardiovascular performance by platelet-activating factor: Relevance to multiple systems organ failure. Crit. Care Clin 5: 331-351, 1989
13. LEFER, A. M. AND MA, X. L.: Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler. Thromb, 13: 771-776, 1993.
14. LEWIS, L. A. AND NAITO, H. K.: Relation of hypertension, lipids and lipoproteins to atherosclerosis. Clin. Chem. 24: 2081-2098, 1978.
15. LOALDI, A., MONTORSI, P., FABBIOCCHI, F., POLESE, A., GUAZZI, M., DECESARE, N. AND GUAZZI, M. D.: Angiographic evolution of coronary atherosclerosis in patients receiving propanolol, a two-year follow-up. Chest 99: 1238-1242, 1991.
16. LUCCHESI, B. R., WERNS, S. W. AND FANTONE, J C : The role of the neutrophil and free radicals in ischemic myocardial injury. J. Mol. Cell. Cardiol. 21: 1241-1251, 1989.
17. MA, X. L. AND LEFER, A. M.: S-nitroso-N-acetylpenicillamine is a potent inhibitor of neutrophil-endothelial interaction. Endothelium 1: 31-39, 1993.
18. MA, X. L., JOHNSON III, G. AND LEFER, A. M.: Superoxide dismutase and a stable prostacyclin analog in myocardial ischemia and reperfusion. J. Am. Coll. Cardiol. 19: 197-204, 1992.
19. MACMAHON, S. W., CUTLER, J. A , NEATON, J. D., HURBERG, C. D , COHEN, J. D., KULLER, L. H. AND STAMLER, J.: Relationship of blood pressure to coronary and stroke morbidity and mortality in clinical trials and epidemiological studies. J. Hypertens. 4: suppl 6, 14-17, 1986.
20. MACMAHON, S. W., CUTLER, J. A., STAMLER, J.: Antihypertensive drug treatment: Potential, expected, and observed effects on stroke and coronary heart disease. Hypertension 18: suppl 1, 45-50, 1989.
21. MOILANEN, E., VUORINEN, P., KANKAARERANTA, H., METSA-KETELA, T. AND VAPAATALO, H.: NO donors inhibit human neutrophil activation in vivo. J. Vasc. Res. 29: 170, 1992.
22. MULLANE, K. M., KRAEMER, R. AND SMITH, B.: Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods 4: 157-167, 1985.
23. OHARA, Y., PETERSON, T. E. AND HARRISON, D. G.: Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91: 2546-2551, 1993.
24. PALMER, R. M. J., FERRIGE, A. G. AND MONCADA, S.: Nitric oxide release accounts for the biological activity of endothelium relaxing factor. Nature (Lond.) 327: 524-526, 1987.
25. ROBERTS, W. C.: Recent studies on the effects of beta blockers on blood lipid levels. Am. Heart J. 117: 709-714, 1989.
26. RUBANYI, G. M. AND VANHOUTTE, P. M.: Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 250: H822-H827, 1986.
27. SEKI, N., NAGAO, T., KOMORI, K. AND SUZUKI, H.: Alpha and beta adrenoceptor blocking action of carvedilol in the canine mesenteric artery and vein. J. Pharmacol. Exp. Ther. 246: 1116-1122, 1988.
28. VANE, J. R. AND BETTING, H. M.: Endothelium-derived vasoactive factors and the control of the circulation. Sem. Perinatol. 15: 4-10, 1991.
29. WERNS, S. W. AND LUCCHESI, B. R.: Free radicals and ischemic tissue injury. Trends Pharmacol. Sci 11: 161-166, 1990.
30. WHITE, G. E., BROCK, T. M., CHANG, L. Y., CRAPO, J., BRISCOE, P., KU, D., BRADLEY, W. A., GIANTURCO, S. H., GORE, J. AND FREEMAN, B. A.: Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 91: 1044-1048, 1994.
31. YUE, T. L., CHENG, H. Y., LYSKO, P. G. ET AL.: Carvedilol, a new vasodilator and β-adrenoceptor antagonist, is an antioxidant and free radical scavenger. J. Pharmacol. Exp. Ther. 263: 92-98, 1992a.
32. YUE, T. L. AND FEUERSTEIN, G. Z.: Carvedilol, a new vasodilator and β-adrenoceptor antagonist, inhibits oxygen radical mediated lipid peroxidation in swine ventricular membranes. Pharmacol. Comm. 1: 27-35, 1992b.
33. YUE, T. L., MCKENNA, P. J. AND CHENG, H. Y.: Carvedilol, a new antihypertensive agent, prevents oxidative injury to endothelial cells. Hypertension 22: 922-928, 1993.
34. YUE, T. L., MCKENNA, P. J., RUFFOLO, R. R. AND FEUERSTEIN, G. Z.: Carvedilol, a new β-adrenoreceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils. Eur. J. Pharm. 214: 277-280, 1992c.